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Toward a Better Understanding of...
The Potential Role of  ER-Associated 




Multiple myeloma (MM) accounts for 13% of hematologic cancers and is characterized 
by a diversity of genetic lesions—translocations, copy number alterations, and single 
nucleotide variants. We designed a single-platform targeted sequencing approach capable 
of detecting all three variant types. Here, we focused on the translocations. We performed 
targeted sequencing of myeloma cells from MM patients (n=96) and detected novel IgH 
translocations with partners near DERL3 (n=2) and observed outlying expression of 
DERL3 from RNA-seq data. Since DERL3 regulates protein misfolding, we hypothesized 
that knockdown of DERL3 in MM would lead to increased apoptosis. After validating 
the translocation via PCR, we knocked down DERL3 with shRNA constructs in MM cell 
lines and observed increased cell death in one of two MM cell lines. This study provided 
some evidence suggesting DERL3 may play a role in regulating MM progression and may 
be a target of IgH-induced overexpression. Identifying DERL3 as a tumor suppressor 
gene for MM could lead to increased understanding of MM development and potential 
use for therapy. 
